VISCHER AG advises Polyphor AG on the deal. Walder Wyss advises Enbiotix Inc. on this transaction. Polyphor (SIX: POLN) and EnBiotix Inc., a privately held late...
You must be a Standard 1 Year member to access this content.
Pestalozzi advised Ringier on the deal. Walder Wyss AG acted as legal counsel to TX Group AG. Bär & Karrer acts as legal advisor to La...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Astrocast SA on the deal. Astrocast SA, the leading Swiss IoT- focused nanosatellite company, floated its shares on the Euronext Growth market in...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised lead investor Revaia on the deal. Wenger Vieli advised Frontify. Frontify AG, a leading provider of brand management software, raised an additional USD...
You must be a Standard 1 Year member to access this content.
Cleary Gottlieb and Walder Wyss represented International Flavors & Fragrances in the transaction. Clifford Chance advised Citi. Freshfields has advised LANXESS. International Flavors & Fragrances (IFF)...
You must be a Standard 1 Year member to access this content.
ARQIS has advised Liberta Partners on the deal. Walder Wyss and Grüter Rechtsanwälte advised H&T Presspart. Liberta Partners sold novelex AG to H&T Presspart, a division...
You must be a Standard 1 Year member to access this content.
Bär & Karrer acted as Lead Counsel to Triton Fund V, alongside with Latham & Watkins LLP (Germany) and Allen & Overy LLP (Netherlands and Belgium)....
You must be a Standard 1 Year member to access this content.
Niederer Kraft Frey advised Invision on the deal. Walder Wyss advised Evoco AG. Invision, a leading investment company focused on succession solutions and growth financing in...
You must be a Standard 1 Year member to access this content.
Paul Hastings advised J.P. Morgan and Barclays Bank PLC on the deal. Walder Wyss and DLA Piper advised MKS Instruments. MKS Instruments, Inc. (NASDAQ: MKSI) (“MKS”),...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Stragen Pharma and its shareholders in the transaction. Homburger acted as Swiss legal counsel to ArchiMed. Private equity healthcare fund ArchiMed announced the...
You must be a Standard 1 Year member to access this content.
Walder Wyss has advised Imburse on this transaction. Cloud based payments integration platform provider Imburse has announced the completion of a USD 12 million Series A...
You must be a Standard 1 Year member to access this content.
Walder Wyss has advised Swisscanto Invest by Zürcher Kantonalbank on the deal. Sulzer Schmid has completed a series B round. The company achieved significant growth in 2020,...
You must be a Standard 1 Year member to access this content.
